Dapagliflozin maintains glycaemic control while reducing weight and body fat mass over 2 years in patients with type 2 diabetes mellitus inadequately controlled on metformin - Bolinder, J; Ljunggren, Ö; Johansson, L (Diabetes Obes Metab, 2014)
et al.